Actively Recruiting

Phase Not Applicable
Age: 18Years - 23Years
All Genders
Healthy Volunteers
NCT06507722

Night Owl Metabolism

Led by Johns Hopkins University · Updated on 2026-05-11

70

Participants Needed

1

Research Sites

257 weeks

Total Duration

On this page

Sponsors

J

Johns Hopkins University

Lead Sponsor

L

Lawson Wilkins Pediatric Endocrine Society

Collaborating Sponsor

AI-Summary

What this Trial Is About

The proposed study uses a novel and rigorous randomized cross-over study design in youth (18-23y) with late and non-late chronotype (n=35 per group) to assess the glycemic effect of "aligning" an oral glucose tolerance test (OGTT) or first-meal of day to a subject's chronotype. Both groups will undergo 2 OGTTs (aligned and mis-aligned with chronotype) to compare glucose tolerance and insulin sensitivity within-subject (primary outcome) and between groups (Aim 1). Then, youth will also undergo two standardized meals (aligned and mis-aligned with chronotype) while wearing continuous glucose monitoring to compare post-prandial glucose excursions within-subject and between groups (Aim 2). A pilot Exploratory Aim 3 (n=12 per group) will investigate delayed melatonin patterns under dim-light as a potential pathophysiologic mechanism behind abnormal glucose tolerance in youth with late chronotype on morning OGTTs.

CONDITIONS

Official Title

Night Owl Metabolism

Who Can Participate

Age: 18Years - 23Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Overweight with BMI at or above the 85th percentile but below the 95th percentile for age and sex (or equivalent for 20-year-olds if age 21-23)
  • Post-pubertal
  • Normal sleep duration averaging more than 7 hours per night
  • Social jetlag (difference between weekend and weekday sleep) less than 2 hours
Not Eligible

You will not qualify if you...

  • Known diabetes, sleep disorders, major organ system illness, pregnancy, or genetic syndromes
  • Use of medications affecting insulin sensitivity, glucose tolerance, or circadian rhythm
  • High risk for obstructive sleep apnea based on screening
  • Night shift work

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Johns Hopkins School of Medicine

Baltimore, Maryland, United States, 21287

Actively Recruiting

Loading map...

Research Team

T

Talia Hitt, MD/MPH/MSHP

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here